Assessment and treatment of osteoporotic hip fractures;Udredning og behandling af osteoporotiske hoftefrakturer

Ugeskrift for Laeger

Volumn 172, Issue 9, 2010, Pages

  Eiken, Pia A ^a   Abrahamsen, Bo ^a  

^a HILLERØD HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE; ZOLEDRONIC ACID;

AGED; ARTICLE; BONE DENSITY; CLINICAL PRACTICE; HIP FRACTURE; HUMAN; LIFESTYLE; MIDDLE AGED; OSTEOPOROSIS; PATHOLOGIC FRACTURE; QUESTIONNAIRE; RISK FACTOR;

AGED; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FRACTURES, SPONTANEOUS; HIP FRACTURES; HUMANS; IMIDAZOLES; LIFE STYLE; MIDDLE AGED; OSTEOPOROSIS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RISK FACTORS;

EID: 77951651635     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Klotzbuecher CM, Ross PD, Landsman PB et al. Patients with prior fractures have an increased risk of fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000;15:721-39.
2. Kanis JA, Melton LJ, III, Christiansen C et al. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41.
3. Melton LJ, III, Thamer M, Ray NF et al. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 1997;12:16-23.
4. McLellan AR, Gallacher SJ, Fraser M et al. The fracture liason service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporosis Int 2003;14:1028-34.
5. Kanis JA, Burlet N, Cooper C et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis Int 2008;19:399-428.
6. Roerholt C, Eiken P, Abrahamsen B. Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteporosis Int 2009;20:299-307.
7. Eiken P. Osteoporose udredning, profylakse og behandling på danske ortopædkirurgiske sygehuse. Ugeskr læger 1996;158:5790-3.
8. Elliot-Gibson V, Bogoch ER, Jamal SA et al. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporosis Int 2004;15:767-78.
9. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-9.
10. Rozental TD, Makhni EC, Day CS et al. Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention. J Bone Joint Surg Am 2008;90:953-61.
11. Sander B, Elliot-Gibson V, Beaton DE et al. A Coordinator program in post-fracture osteoporosis management improves outcome and saves costs. J Bone Joint Surg AM 2008; 90:1197-1205.
12. Majumdar SR, Johnson JA, McAlister FA et al. Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial. CMAJ 2008;178:569-75.
13. Bogoch ER, Elliot-Gibson V, Beaton DE et al. Effective initiation of osteoporosis diagnosis and treatment for patients with fragility fracture in an orthopaedic environment. J Bone Joint Sur Am 2006;88:25-34.
14. Tang BM, Eslick GD, Nowson C et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007;370:657-66.
15. Lyles KW, Colón-Emeric CS, Magaziner JS et al. Zoledronic acid in reducing clinical fracture and mortality after hip fracture. N Engl J Med 2007;357:1799-1809.
16. Black DM, Cummings SR, Karpf DM et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996;348:1535-41.
17. McClung MR, Geusens P, Miller PD et al. Effects of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-40.
18. Reginster J-Y, Felsenberg D, Boonen S et al. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenoapusal osteoporosis. Results of a five-year, randomized, placebo-controlled trial. Arthr & Rheuma 2008;58:1687-95.
19. Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.
20. Eiken P, Thorsteinsson B. Effekten af motion på forebyggelsen af osteoporose hos ældre. Månedskrift Prak Lægegern 2007;9:927-36.